Alexion Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
EC 2018 Outlook – Biotech Bonanza: Biotech Stocks To Keep Shining
Article By: Tarun Chandra, CFA
Sunday, December 17, 2017 11:58 AM EST
Biotech is not an easy sector to invest in - 95 percent of the oncology drugs that enter clinical trials fail. But that is no reason to ignore biotechs. We believe biotech stocks in 2018 will deliver double-digit returns of around 20%.
In this article: ALNY, ALXN, ABEO Also: ASH, ARNA, AMGN, BIIB, ANAB, SPPI, ZGNX, NKTR, EXAS, SAGE, HALO, SGMO, DVAX, INSM, XBI, JUNO, ESPR, LOXO, RVNC, LABD, LABU, BPMC, MRTX, NVS, CLLS, BLUE, BMY, INCY, CELG, GILD, VRTX, REGN
Read
Goldman Thinks It’s Time You ‘Sharpe’n Up
Article By: The Heisenberg Report
Saturday, December 16, 2017 3:30 PM EST
You damn sure can’t try to be a hero by betting against this self-fulfilling prophecy because that’s a one-way ticket to underperformance in a world where change has become impossible.
In this article: RRC, TAP, WDC, XRX, ALXN, DISH
Read
Biotech: Opportunity Ahead!
Article By: Tarun Chandra, CFA
Thursday, November 30, 2017 2:18 PM EST
December can prove to be a month of opportunity. We believe the passage of tax cuts this year can be the catalyst that jolts the biotech sector, to recover back the recent declines and even make new 52-week highs.
In this article: ALNY, ALXN, ABEO
Read
3 ETFs To Watch On Biotech Earnings
Article By: Zacks Investment Research
Sunday, October 29, 2017 5:13 PM EST
The earnings season is off to a flying start with equity markets. However, the performance has been a mixed bag for biotech companies with some beating market expectations, while a few failed to do so.
In this article: ALXN, AMGN, BIIB, BIB, IBB, BBH, GILD
Read
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Article By: Arpita Dutt
Monday, October 2, 2017 10:16 AM EST
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read

PARTNER HEADLINES

Latest Tweets for $ALXN

No tweets yet!